A value dossier is a comprehensive document that articulates the value proposition of medical technology, serving as a strategic tool for market access and stakeholder engagement. It serves multiple purposes:
- Facilitating market access engagement – Equipping market access teams with the necessary insights to engage effectively with payers and other stakeholders
- Providing a centralized evidence repository – Establishing a single, consistent source of validated data to support regulatory submissions, reimbursement negotiations, and commercial strategy
- Guiding tailored value communication – Ensuring clear, compelling messaging for diverse audiences, including payers, healthcare professionals, and regulatory agencies.
- Differentiating technology in the market – Demonstrating how the product offers advantages over existing treatment options, highlighting its clinical and economic benefits.
Key insights covered in this White Paper:
- Market access strategy – How value dossiers support payer negotiations and stakeholder engagement.
- Evidence synthesis – Consolidating clinical, economic, and real-world evidence to present a compelling value narrative.
- Centralized information hub – The role of the dossier as a consistent, validated resource across product teams and external stakeholders.
- Tailored communication approaches – Adapting messaging for payers, healthcare professionals, regulatory bodies, and patient advocacy groups.
- Types of value dossiers – Detailed descriptions of comprehensive, early, and exploratory dossiers designed to support distinct product lifecycle needs.
This White Paper provides actionable insights for developing high-quality, evidence-based value dossiers that meet stakeholder expectations and strengthen market access efforts in the competitive MedTech landscape.
Request White Paper
Request an Analytical White Paper and explore the role and structure of Value Dossiers in MedTech